Psyence Biomedical Company Leadership
| PBM Stock | USD 3.46 0.05 1.42% |
Psyence Biomedical employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Psyence Biomedical's management performance can provide insight into the firm performance.
Psyence |
Psyence Biomedical Management Team Effectiveness
The company has Return on Asset of (1.2635) % which means that on every $100 spent on assets, it lost $1.2635. This is way below average. Psyence Biomedical's management efficiency ratios could be used to measure how well Psyence Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Psyence Biomedical's Return On Capital Employed is very stable compared to the past year. As of the 1st of December 2024, Return On Equity is likely to grow to 4.90, though Return On Tangible Assets are likely to grow to (42.93). At this time, Psyence Biomedical's Total Current Assets are very stable compared to the past year. Non Currrent Assets Other is expected to grow at the current pace this year, while Total Assets are likely to drop about 1.1 M.As of the 1st of December 2024, Common Stock Shares Outstanding is likely to grow to about 11.4 M
Psyence Biomedical Workforce Comparison
Psyence Biomedical Ltd is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 7,549. Psyence Biomedical adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Psyence Biomedical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Psyence Biomedical Price Series Summation is a cross summation of Psyence Biomedical price series and its benchmark/peer.
Psyence Biomedical Notable Stakeholders
A Psyence Biomedical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Psyence Biomedical often face trade-offs trying to please all of them. Psyence Biomedical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Psyence Biomedical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jody Aufrichtig | Executive CoFounder | Profile | |
| Neil MD | CEO Director | Profile | |
| Taryn Vos | General Counsel | Profile | |
| Tony Budden | Chief Officer | Profile | |
| MaryElizabeth Gifford | Executive Impact | Profile | |
| Warwick CordenLloyd | Chief Officer | Profile |
About Psyence Biomedical Management Performance
The success or failure of an entity such as Psyence Biomedical often depends on how effective the management is. Psyence Biomedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Psyence management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Psyence management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (45.19) | (42.93) | |
| Return On Capital Employed | 0.25 | 0.26 | |
| Return On Assets | (45.19) | (42.93) | |
| Return On Equity | 4.66 | 4.90 |
Psyence Biomedical Workforce Analysis
Traditionally, organizations such as Psyence Biomedical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Psyence Biomedical within its industry.Psyence Biomedical Manpower Efficiency
Return on Psyence Biomedical Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 8.5M | |
| Net Loss Per Executive | 8.5M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.82) | Return On Assets (1.26) |
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.